Anika Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Anika Therapeutics (ANIK) Tops Q3 EPS by 22c
October 24, 2018 4:35 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.53, $0.22 better than the analyst estimate of $0.31. Revenue for the quarter came in at $26.8 million versus the consensus estimate of $27 million.
The increase in net income was due primarily to the reduction... More
